MyAverix Finance
US · Healthcare
Cannabis Strategic Ventures (NUGS)
Drug Manufacturers - Specialty & Generic
Cannabis Strategic Ventures (NUGS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NUGS
Cannabis Strategic Ventures (NUGS) — FAQ
What is NUGS's P/E ratio?
The price-to-earnings (P/E) ratio for Cannabis Strategic Ventures (NUGS) is 18.00 (data as of 2026-03-24).
Does Cannabis Strategic Ventures pay a dividend?
Dividend yield is not available in the current snapshot for Cannabis Strategic Ventures (NUGS). Check the MyAverix Finance app for the latest dividend data.
What sector is Cannabis Strategic Ventures in?
Cannabis Strategic Ventures (NUGS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is NUGS listed on?
NUGS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.